Latest News

Semaglutide (Wegovy, Novo Nordisk) is a new drug that can be used to support people to reduce their weight by over 10%. Wegovy has been approved by NICE and will be made available on the NHS for those who meet the criteria.

The new ‘Bill’ will include significant changes to current UK laws increasing online protection for vulnerable people, including children and young people (CYP) by criminalising the encouragement of self-harm and the sharing of people’s intimate images without their consent.

At a time when the NHS is facing unprecedented resource challenges, ABL Health – the winner of this year’s Bridges Positive Impact Award